BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29266383)

  • 1. Association between extremity kaposiform hemangioendothelioma and lymphedema.
    Konczyk DJ; Goss JA; Maclellan RA; Greene AK
    Pediatr Dermatol; 2018 Jan; 35(1):e92-e93. PubMed ID: 29266383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y; Kong L; Sun B; Cui J; Shen W
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S; Cassarino DS
    JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract]   [Full Text] [Related]  

  • 4. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
    Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
    Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W; Li K; Wang Z; Dong K; Zheng S
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.
    Wang Z; Li K; Dong K; Xiao X; Zheng S
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):72-3. PubMed ID: 24309604
    [No Abstract]   [Full Text] [Related]  

  • 10. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
    Alonso Arroyo V; Lopez-Gutierrez JC; Martinez R; Fernandez-Pineda I
    Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansile kaposiform hemangioendothelioma deformed thoracic cage in an adult.
    Wu CH; Tsai TM; Liau JY; Chang YL; Lai HS; Lee JM
    Ann Thorac Surg; 2013 Nov; 96(5):1854-7. PubMed ID: 24182473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthestic management of Kassabach-Meritt Phenomenon in an adult: case report.
    Elkoundi A; Samali M; Kartite N; Tbouda M; Bensghir M; Haimeur C
    BMC Anesthesiol; 2016 Nov; 16(1):109. PubMed ID: 27829366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kaposiform hemangioendothelioma in a neonate associated with Kasabach-Merritt phenomenon: case report].
    Huang X; Wei B; Jiang Y
    Zhonghua Er Ke Za Zhi; 2015 Oct; 53(10):790-1. PubMed ID: 26758119
    [No Abstract]   [Full Text] [Related]  

  • 14. Multifocal kaposiform hemangioendothelioma in multiple visceral organs: an autopsy of 9-day-old female baby.
    Nakaya T; Morita K; Kurata A; Ushiku T; Igarashi T; Kuroda M; Fukayama M
    Hum Pathol; 2014 Aug; 45(8):1773-7. PubMed ID: 24931465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.
    Jiang RS; Hu R
    Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon].
    Inguanzo-Ortiz M; Piqué-Duran E; Aparicio-Sánchez JL; Vaca-Arellano MR
    An Pediatr (Engl Ed); 2018 May; 88(5):292-293. PubMed ID: 29625805
    [No Abstract]   [Full Text] [Related]  

  • 17. Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon.
    Das A; Bansal D; Chatterjee D; Das A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):153-154. PubMed ID: 27820128
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
    Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Russell TB; Rinker EK; Dillingham CS; Givner LB; McLean TW
    Pediatrics; 2018 Apr; 141(Suppl 5):S421-S424. PubMed ID: 29610164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.
    Fuchimoto Y; Morikawa N; Kuroda T; Hirobe S; Kamagata S; Kumagai M; Matsuoka K; Morikawa Y
    Pediatr Int; 2012 Apr; 54(2):285-7. PubMed ID: 22507155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.